(Q33379544)

English

Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study

scientific article

Statements

Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit